These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 6500755)

  • 21. Characteristics of patients with liver disease intravenously exposed to diethylene glycol in China 2006.
    Peng XM; Huang MX; Gu L; Lin BL; Chen GH
    Clin Toxicol (Phila); 2009 Feb; 47(2):124-31. PubMed ID: 18792827
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Antipyrine clearance and its correlation to routine liver function tests in patients with liver disease.
    Krausz Y; Zylber-Katz E; Levy M
    Int J Clin Pharmacol Ther Toxicol; 1980 Jun; 18(6):253-7. PubMed ID: 7450926
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The creatinine approach to estimate skeletal muscle mass in patients with cirrhosis.
    Pirlich M; Selberg O; Böker K; Schwarze M; Müller MJ
    Hepatology; 1996 Dec; 24(6):1422-7. PubMed ID: 8938174
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Influence of cigarette smoke on antipyrine metabolite formation in rats.
    Nakagawa A; Chiba K; Ishizaki T; Nakamura K
    Res Commun Chem Pathol Pharmacol; 1983 Sep; 41(3):473-91. PubMed ID: 6635330
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Determination of the sulphoxides and sulphones of three simple sulphides in rat urine: effects of phenobarbitone, beta-naphthoflavone and methimazole.
    Nnane IP; Damani LA
    Biomed Chromatogr; 2005 Jan; 19(1):87-98. PubMed ID: 15470701
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Intestinal permeability compared in pediatric and adult patients with inflammatory bowel disease.
    Issenman RM; Jenkins RT; Radoja C
    Clin Invest Med; 1993 Jun; 16(3):187-96. PubMed ID: 8365046
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Validity of 13C-phenylalanine breath test to evaluate functional capacity of hepatocyte in patients with liver cirrhosis and acute hepatitis.
    Koeda N; Iwai M; Kato A; Suzuki K
    Aliment Pharmacol Ther; 2005 Apr; 21(7):851-9. PubMed ID: 15801920
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Thiamin Metabolism in the rat during long-term alcohol administration. 1. Communication: ethanol induced changes at optimal thiamin supply.
    Bitsch R; Hansen J; Hötzel D
    Int J Vitam Nutr Res; 1982; 52(2):126-33. PubMed ID: 6890048
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Comparison of the effects of phenobarbital and its hydroxylated metabolites on drug-metabolizing enzymes during ontogenesis.
    Cresteil T; Mahu JL; Beaune P; Columelli S; Leroux JP
    Pediatr Pharmacol (New York); 1981; 1(4):331-40. PubMed ID: 6810295
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Marked effect of liver and kidney function on the pharmacokinetics of selegiline.
    Anttila M; Sotaniemi EA; Pelkonen O; Rautio A
    Clin Pharmacol Ther; 2005 Jan; 77(1):54-62. PubMed ID: 15637531
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The influence of renal function on plasma levels and urinary excretion of acebutolol and its main N-acetyl metabolite.
    Kirch W; Köhler H; Berggren G; Braun W
    Clin Nephrol; 1982 Aug; 18(2):88-94. PubMed ID: 7140021
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Modification of the mutagenicity and teratogenicity of cyclophosphamide in rats with inducers of the cytochromes P-450.
    Hales BF
    Teratology; 1981 Aug; 24(1):1-11. PubMed ID: 7029774
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Thiamine propyl disulfide: absorption and utilization.
    Thomson AD; Frank O; Baker H; Leevy CM
    Ann Intern Med; 1971 Apr; 74(4):529-34. PubMed ID: 5551161
    [No Abstract]   [Full Text] [Related]  

  • 34. [Initial trial of a new test for the evaluation of hepatocellular function: the TMB test].
    Rousselet F; Charbonnier A; Fredj G; Nepveux P; Fluteau G; Cachin M
    Sem Hop; 1977 May; 53(18-19):1049-51. PubMed ID: 196339
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Further studies on the urinary metabolites of thiamine propyl disulfide in rats.
    Nishikawa K; Suzuoki Z; Numata M
    J Pharmacol Exp Ther; 1967 Sep; 157(3):589-98. PubMed ID: 4860357
    [No Abstract]   [Full Text] [Related]  

  • 36. ABSORPTION AND EXCRETION OF THIAMINE PROPYL DISULFIDE-S35. II. ABSORPTION AND EXCRETION OF THIAMINE PROPYL DISULFIDE-S35 (INNER).
    TAKENOUCHI K; ASO K
    J Vitaminol (Kyoto); 1964 Jun; 10():142-53. PubMed ID: 14217465
    [No Abstract]   [Full Text] [Related]  

  • 37. The absorption of radioactive sulphur-labelled thiamine hydrochloride in control subjects and in patients with intestinal malabsorption.
    Thomson AD
    Clin Sci; 1966 Oct; 31(2):167-79. PubMed ID: 5955719
    [No Abstract]   [Full Text] [Related]  

  • 38. [Pharmacokinetics of sulfachlorpyridazine].
    Mariño EL; Tabernero JM; Macías JG; Domínguez-Gil A; de Castro S
    Arch Farmacol Toxicol; 1979 Apr; 5(1):57-71. PubMed ID: 475478
    [No Abstract]   [Full Text] [Related]  

  • 39. Comparison of turnover of thiamine propyl disulfide and thiamine in various organs on oral or parenteral administration to rats.
    Itokawa Y; Ikeda K; Fujiwara M
    J Vitaminol (Kyoto); 1968 Jun; 14(2):134-41. PubMed ID: 5723130
    [No Abstract]   [Full Text] [Related]  

  • 40. Studies on the intestinal absorption of thiamine, riboflavin and calcium in liver damage.
    Miyao M; Matsuda H; Usui T; Tanaka H; Kochi T
    Tokushima J Exp Med; 1967 Jun; 14(1):1-12. PubMed ID: 6080935
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.